Skip to content
by Legal Desire
SIGN IN GO PRO
Lawyer profile

Sloan Ungerman

Latham & Watkins LLP
Claim this profile
Firm
Latham & Watkins LLP
Practice
derivatives, equity derivatives
Office
Not stated
Active in the record
2024 to 2026

Deal experience

Deal types
Capital Markets & IPOM&A
Sectors
Financial ServicesHealthcare & Life SciencesTelecoms & Media
Jurisdictions
MexicoUnited States

Deals

4 announced deals in the record
Latham & Watkins Advises on Adaptive Biotechnologies’ Upsized US$300 Million Convertible Senior Notes Offering 24 Jun 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 300m derivatives
Latham & Watkins Advises Mexican Airline Volaris on Merger of Equals With Viva 23 Dec 2025
M&A Telecoms & Media Latham & Watkins LLP derivatives
Latham & Watkins Advises on Halozyme Therapeutics’ Convertible Senior Notes Offerings Totaling US$1.3 Billion 8 Nov 2025
Capital Markets & IPO Financial Services Latham & Watkins LLP USD 1.30bn derivatives
Latham & Watkins Advises on Itron, Inc.’s Upsized US$805 Million Convertible Senior Notes Offering 28 Jun 2024
Capital Markets & IPO Financial Services Latham & Watkins LLP USD 805m equity derivatives
Deal alerts PRO

Get an email when Sloan Ungerman is named on a newly announced deal.

See Pro plans

Alerts come as one daily email at most.

Pro

Analytics for Sloan Ungerman

The paid plans add analytics for this lawyer, and for every firm and lawyer in the database:

  • Complete deal history, filtered by keyword, deal type, sector and year
  • Deals by year, sector and deal type
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • CSV and Excel export
SEE PLANS SIGN IN
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction